Gemcitabine as single agent in the treatment of elderly patients with advanced non small cell lung cancer

Anticancer Research

Volumn 20, Issue 5 C, 2000, Pages 3675-3678

  Altavilla, G ^a   Adamo, V ^a   Buemi, B ^a   Marabello, G ^a   Maisano, R ^a   Lupo, G ^a   Bene, A ^a   Bellocco, G ^a  

^a UNIVERSITY OF MESSINA   (Italy)

Author keywords

Elderly; Gemcitabine; Non small cell lung cancer; Phase II

Indexed keywords

GEMCITABINE;

ADVANCED CANCER; AGED; AGING; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; LEUKOPENIA; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; RISK BENEFIT ANALYSIS; THROMBOCYTOPENIA;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; ANTIMETABOLITES, ANTINEOPLASTIC; CARCINOMA, LARGE CELL; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; DEOXYCYTIDINE; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; NEOPLASM STAGING; QUALITY OF LIFE; QUESTIONNAIRES; SURVIVAL RATE;

EID: 0034535504     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Cancer statistics
2. Chemotherapy in non small cell lung cancer: A meta-analysis using updated data on individual patient data from 52 randomised clinical trials
3. New chemotherapeutic agents prolong survival and improve quality of life in non small cell lung cancer. A review of the literature and future directions
4. Gemcitabine: Current status of phase I and II trials
5. Gemcitabine: Safety profile and efficacy in non small cell lung cancer unaffected by age
6. Reporting results of cancer treatment
7. Quality of life assessment in individuals with lung cancer: Testing the lung cancer symptom scale. (LCSS)
8. Gemcitabine in the treatment of elderly patients with advanced non small cell lung cancer
9. Single agent activity of gemcitabine in advanced non-small cell lung cancer
10. Vinorelbine is well tolerated and active in the treatment of elderly patients with advanced non small cell lung cancer. A two stage phase II study
11. Symptom relief with MVP (mitomycin c, vinblastine and cisplatin) chemotherapy in advanced non small cell lung cancer
12. Mitomycin, ifosfamide and cisplatin in unresectable non small cell lung cancer: Effect on survival and quality of life
13. Gemcitabine: Symptomatic benefit in advanced non small cell lung cancer
14. Critical review of international assessment of health related quality of life
15. Quality of life
16. Quality of life assessment in the chemotherapy trials for non small cell lung cancer: Are theory and practise significantly different?
17. Normative data and trends in quality of life from the lung cancer symptom scale (LCSS)
18. Effect of vinorelbine on quality of life and survival of elderly patients with advanced non small cell lung cancer